BioSpace News Archive

30 years of industry experience from CEO of Nasdaq-listed biotech to Vice President, Marketing at Pfizer.

Oxitec Ltd, the leading developer of biological pest control solutions, today announced the launch of the next phase of the company’s malaria vector program, enabled by US$18 million of funding from the Bill & Melinda Gates Foundation.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2022 after market close on Wednesday, May 4, 2022.

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2022 financial results on Wednesday, May 4th, before the market opens.

Gabri Labs, a pharmaceutical technologies company, has announced the development of a 10,000 sq. ft. facility to locally produce medical devices.

Helix BioPharma Corp. is pleased to announce that it has received conditional approval from the Toronto Stock Exchange to extend its previously announced Early Warrant Exercise Incentive Program from April 28, 2022 to May 31, 2022.

InxMed Co., Ltd. announced that IN0018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical Products Administration.

Ascentage Pharma announced that it has presented the latest results from six preclinical studies of the company’s five investigational drug candidates: the Bcl-2 inhibitor lisaftoclax and the MDM2-p53 inhibitor alrizomadlin, two key candidates in the company’s apoptosis-targeted pipeline, as well as the FAK inhibitor APG-2449, the EED inhibitor APG-5918 and the KRAS inhibitor APG-1842, at the 2022 American Association for Cancer Research Annual Meeting.

Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2022, ended March 31, 2022, after the market close on April 27, 2022.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2022 after market close on Thursday, May 5, 2022.